Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (162)

Latest Posts

About This Stock More About This Stock
Negative News Response Syndrome For Stocks?
Article By: Kurt Kallaus
Sunday, October 21, 2018 4:48 PM EST
With the heart of the current earnings season for stocks running from October 16 to November 14, it’s too early to prognosticate with confidence, but there appears to be a shift in how the market is responding to good and bad news.
In this article: CSX, JNJ, PG, UNH, NFLX, PYPL
Johnson & Johnson (JNJ) Surpasses Q3 Earnings And Revenue Estimates
Article By: Zacks Investment Research
Tuesday, October 16, 2018 10:36 AM EST
Johnson & Johnson came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $2.03 per share.
In this article: JNJ
Banks Provide Positive Start To Q3 Earnings Season
Article By: Sheraz Mian
Saturday, October 13, 2018 5:51 PM EST
Bank stocks have been notable laggards in recent quarters, with market participants preferring the faster growing technology stocks to these seemingly boring companies. Banks are boring, but they have a lot going for them.
In this article: JNJ, SLB, NFLX
E Johnson & Johnson: Recession Safety, Growth And Valuation
Article By: SureDividend
Sunday, September 30, 2018 10:26 AM EST
it is a shame to miss the exceptional long-term returns of the stock market due to abstract fears of a bear market.
In this article: JNJ Also: GILD
A Pause That Refreshes?
Article By: Lance Roberts
Saturday, September 29, 2018 5:44 PM EST
Tariffs, higher interest rates, and higher oil prices are ultimately a direct tax on the consumer. Such will ultimately weigh on consumption, earnings, and the economy. Another concern for the rally is the participation continues to narrow.
In this article: SPX, XLRE, XLC, JNJ, PEP, SU, KLAC, MU, GLD


Latest Tweets for $JNJ

No tweets yet!


Johnson & Johnson: Recession Safety, Growth And Valuation
Stuart Saunders 10/1/2018 2:44:49 AM

Inventors, do not trust johnson and Johnson $JNJ

Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs
Bill Myers 7/12/2018 12:37:26 PM

Still not impressed with $JNJ.

1 to 2 of 2 comments